These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10074910)

  • 1. Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors.
    Kyo S; Kanaya T; Takakura M; Tanaka M; Yamashita A; Inoue H; Inoue M
    Int J Cancer; 1999 Mar; 80(6):804-9. PubMed ID: 10074910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues.
    Kyo S; Kanaya T; Takakura M; Tanaka M; Inoue M
    Int J Cancer; 1999 Jan; 80(1):60-3. PubMed ID: 9935231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between human telomerase reverse transcriptase transcriptional level and telomerase activity in three ovarian cancer cell lines].
    Song Y; Kong BH; Liu PS; Ma DX; Jiang S
    Ai Zheng; 2003 May; 22(5):486-91. PubMed ID: 12753708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium.
    Ulaner GA; Hu JF; Vu TH; Oruganti H; Giudice LC; Hoffman AR
    Int J Cancer; 2000 Feb; 85(3):330-5. PubMed ID: 10652422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hTERT is a critical determinant of telomerase activity in renal-cell carcinoma.
    Kanaya T; Kyo S; Takakura M; Ito H; Namiki M; Inoue M
    Int J Cancer; 1998 Nov; 78(5):539-43. PubMed ID: 9808519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of chemosensitivity to anticancer drugs and telomere length, telomerase activity and telomerase RNA expression in human ovarian cancer cells.
    Kiyozuka Y; Yamamoto D; Yang J; Uemura Y; Senzaki H; Adachi S; Tsubura A
    Anticancer Res; 2000; 20(1A):203-12. PubMed ID: 10769656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of the RIalpha subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer.
    McDaid HM; Cairns MT; Atkinson RJ; McAleer S; Harkin DP; Gilmore P; Johnston PG
    Br J Cancer; 1999 Feb; 79(5-6):933-9. PubMed ID: 10070893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer.
    Ito H; Kyo S; Kanaya T; Takakura M; Inoue M; Namiki M
    Clin Cancer Res; 1998 Jul; 4(7):1603-8. PubMed ID: 9676833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The telomerase activity and expression of hTERT gene can serve as indicators in the anti-cancer treatment of human ovarian cancer.
    Sun PM; Wei LH; Luo MY; Liu G; Wang JL; Mustea A; Könsgen D; Lichtenegger W; Sehouli J
    Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):249-57. PubMed ID: 16519988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential telomerase activity, expression of the telomerase catalytic sub-unit and telomerase-RNA in ovarian tumors.
    Park TW; Riethdorf S; Riethdorf L; Löning T; Jänicke F
    Int J Cancer; 1999 Aug; 84(4):426-31. PubMed ID: 10404098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
    Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
    Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of H-Ryk in mouse fibroblasts confers transforming ability in vitro and in vivo: correlation with up-regulation in epithelial ovarian cancer.
    Katso RM; Manek S; Biddolph S; Whittaker R; Charnock MF; Wells M; Ganesan TS
    Cancer Res; 1999 May; 59(10):2265-70. PubMed ID: 10344726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer.
    Takakura M; Kyo S; Kanaya T; Tanaka M; Inoue M
    Cancer Res; 1998 Apr; 58(7):1558-61. PubMed ID: 9537264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer.
    Widschwendter A; Müller HM; Hubalek MM; Wiedemair A; Fiegl H; Goebel G; Mueller-Holzner E; Marth C; Widschwendter M
    Gynecol Oncol; 2004 May; 93(2):407-16. PubMed ID: 15099954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase in (pre)neoplastic cervical disease.
    Wisman GB; De Jong S; Meersma GJ; Helder MN; Hollema H; de Vries EG; Keith WN; van der Zee AG
    Hum Pathol; 2000 Oct; 31(10):1304-12. PubMed ID: 11070123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of telomerase genes in thyroid carcinoma.
    Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
    Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 null mutations are associated with a telomerase negative phenotype in ovarian carcinoma.
    Sood AK; Coffin J; Jabbari S; Buller RE; Hendrix MJ; Klingelhutz A
    Cancer Biol Ther; 2002; 1(5):511-7. PubMed ID: 12496479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
    Takihana Y; Tsuchida T; Fukasawa M; Araki I; Tanabe N; Takeda M
    Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of protease M in ovarian tumors.
    Tanimoto H; Underwood LJ; Shigemasa K; Parmley TH; O'Brien TJ
    Tumour Biol; 2001; 22(1):11-8. PubMed ID: 11054022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the protease inhibitor antileukoprotease and the serine protease stratum corneum chymotryptic enzyme (SCCE) is coordinated in ovarian tumors.
    Shigemasa K; Tanimoto H; Underwood LJ; Parmley TH; Arihiro K; Ohama K; O'Brien TJ
    Int J Gynecol Cancer; 2001; 11(6):454-61. PubMed ID: 11906548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.